News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

Depression and Long COVID Outcomes in Women: New Data Analysis

Presenting Our February 2026 Theme: Bipolar Disorder

Investigational Psilocybin for PTSD and Ongoing Trials

Patterns of Propensity: A Review of Heinrichs’ How Psychiatrists Make Decisions

In Memoriam: Elise Snyder, MD, A Legacy of Mentoring to Psychotherapists in China